We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Home Study on Activities of Coronary Patients

By HospiMedica staff writers
Posted on 04 Feb 2002
A nine-week study has begun to monitor variations in cardiac function of 50 males with coronary artery disease while they are engaged in routine activities at home, including sexual activity. More...
The study is being conducted by researchers at Stanford University (Stanford, CA, USA) in an effort to help doctors better manage heart patients outside a clinical setting.

The subjects will wear a special Holter monitor for at least one 24-hour period each week, which will record electrocardiogram (ECG) data that reflect blood flow to the heart. The subjects are asked to begin the period by applying the Holter monitor prior to engaging in sexual activity. During the nine weeks, the subjects will take both sildenafil (Viagra) and a placebo. The investigators are including the use of sildenafil in order to evaluate the ECG response of sexually active men with heart disease.

The HolterNet cardiac monitor being used in the study is the product of TransMedEx (Melville, NY, USA). The monitor is the size of a pager, uses only five electrodes, and provides diagnostic data comparable to a standard 12-lead ECG, says the company. The test data are available to doctors on a secured Internet site.

"If we are successful in developing cardiac profiles that truly reflect the heart function of patients on a day-to-day basis, we can enhance a physician's ability to monitor and manage the care of patients with heart disease outside the confines of a hospital or clinical setting,” said Robert DeBusk, M.D., professor of medicine at Stanford University School of Medicine.



Related Links:
TransMedEx
Stanford University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.